Platelet immunoglobulin and amyloid precursor protein as potential peripheral biomarkers for Alzheimer's disease: findings from a pilot study
Author(s) -
Elizabeta B. MukaetovaLadinska,
Zeinab AbdelAll,
Steven J. Dodds,
Joana Andrade,
Joaquim Alves da Silva,
Raj N. Kalaria,
John T. O’Brien
Publication year - 2012
Publication title -
age and ageing
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.014
H-Index - 143
eISSN - 1468-2834
pISSN - 0002-0729
DOI - 10.1093/ageing/afr171
Subject(s) - medicine , alzheimer's disease , disease , amyloid (mycology) , antibody , platelet , immunology , immunoglobulin g , pathology
he diagnosis of dementia, in particular Alzheimer's disease (AD), is enhanced with the use of molecular biomarkers. Since cerebrospinal fluid analysis and molecular neuroimaging are not routinely used in many countries, blood biomarker molecules may be more readily applicable in a routine clinical setting.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom